These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1176 related articles for article (PubMed ID: 15916014)

  • 1. Rhinitis and asthma co-morbidity in respiratory allergy due to house dust mite: results of an observational open controlled parallel group study in real-life setting.
    Marogna M; Spadolini I; Massolo A
    Eur Ann Allergy Clin Immunol; 2005 Apr; 37(4):135-42. PubMed ID: 15916014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The allergic march in pollinosis: natural history and therapeutic implications.
    Marogna M; Falagiani P; Bruno M; Massolo A; Riva G
    Int Arch Allergy Immunol; 2004 Dec; 135(4):336-42. PubMed ID: 15564776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.
    Magnan A; Meunier JP; Saugnac C; Gasteau J; Neukirch F
    Allergy; 2008 Mar; 63(3):292-8. PubMed ID: 18028246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of patients with allergic polysensitization: the POLISMAIL study.
    Ciprandi G; Alesina R; Ariano R; Aurnia P; Borrelli P; Cadario G; Capristo A; Carosso A; Casino G; Castiglioni G; Cesinaro Di Rocco P; Colangelolo C; Di Gioacchino M; Di Paola MG; Errico G; Fiorina A; Gambuzza F; Gangemi S; Gasparini A; Giugno R; Iemoli E; Isola S; Maniero G; Marengo F; Mazzali P; Minelli M; Mosca M; Pellegrino R; Piconi S; Pravettoni V; Quaglio L; Ricciardi L; Ridolo E; Sillano V; Valle C; Varin E; Verini M; Zambito M; Riario-Sforza GG; Incorvaia C; Puccinelli P; Scurati S; Frati F
    Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):77-83. PubMed ID: 19334371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingual immunotherapy for allergic respiratory disease in elderly patients: a retrospective study.
    Marogna M; Bruno ME; Massolo A; Falagiani P
    Eur Ann Allergy Clin Immunol; 2008 May; 40(1):22-9. PubMed ID: 18700331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children multicenter trial.
    Acquistapace F; Agostinis F; Castella V; Kantar A; Novembre E; Perrone MR; Pietrasanta M; Sambugaro R; Milani M
    Pediatr Allergy Immunol; 2009 Nov; 20(7):660-4. PubMed ID: 19320852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
    Kopp MV; Hamelmann E; Zielen S; Kamin W; Bergmann KC; Sieder C; Stenglein S; Seyfried S; Wahn U;
    Clin Exp Allergy; 2009 Feb; 39(2):271-9. PubMed ID: 19016798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France.
    Omnes LF; Bousquet J; Scheinmann P; Neukirch F; Jasso-Mosqueda G; Chicoye A; Champion L; Fadel R
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):148-56. PubMed ID: 17626329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case control study of dermatophagoides immunotherapy in children below 5 years of age.
    Di Bernardino C; Di Bernardino F; Colombo R; Angrisano A
    Allerg Immunol (Paris); 2002 Feb; 34(2):56-9. PubMed ID: 11933755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma.
    Antonicelli L; Micucci C; Voltolini S; Senna GE; Di Blasi P; Visonà G; De Marco R; Bonifazi F
    Allergy; 2007 Sep; 62(9):1064-70. PubMed ID: 17686109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy in the context of a clinical practice improvement program in the allergological setting: results of a long-term observational study.
    Marogna M; Massolo A
    Eur Ann Allergy Clin Immunol; 2003 Apr; 35(4):133-40. PubMed ID: 12793117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting effects of sublingual immunotherapy for house dust mites in allergic rhinitis with bronchial hyperreactivity: A long-term (13-year) retrospective study in real life.
    Marogna M; Bruno M; Massolo A; Falagiani P
    Int Arch Allergy Immunol; 2007; 142(1):70-8. PubMed ID: 17016060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule 1 and tumor necrosis factor alpha in asthma and persistent allergic rhinitis: relationship with disease severity.
    Gorska-Ciebiada M; Ciebiada M; Gorska MM; Gorski P; Grzelewska-Rzymowska I
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):66-72. PubMed ID: 16892784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of allergic rhinitis on asthma: effects on spirometric parameters.
    Ciprandi G; Cirillo I; Pistorio A
    Allergy; 2008 Mar; 63(3):255-60. PubMed ID: 17944984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
    La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
    Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms.
    Crimi N; Li Gotti F; Mangano G; Paolino G; Mastruzzo C; Vancheri C; Lisitano N; Polosa R
    Ann Ital Med Int; 2004; 19(2):98-108. PubMed ID: 15317270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of high-dose sublingual immunotherapy in children allergic to house dust mites in real-life clinical practice.
    Ferrés J; Justicia JL; García MP; Muñoz-Tudurí M; Alvà V
    Allergol Immunopathol (Madr); 2011; 39(3):122-7. PubMed ID: 20570032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
    Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.